CANF and CFBI Related Headlines
Go Back- Can-Fite raises $4 million through warrant exercise agreement
- Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
- Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
- Can-Fite Provides Update on Clinical and Financial Status
- Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
- Can-Fite achieves 50% enrollment in pancreatic cancer drug trial
- Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone
- Can-Fite prices $15 million public offering with institutional investor
- Can-Fite Announces Up To $15.0 Million Public Offering
CANF and CFBI Related Press Releases
Go Back- Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
- Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
- Can-Fite Provides Update on Clinical and Financial Status
- Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
- Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone
- Can-Fite Announces Up To $15.0 Million Public Offering
